Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
05/2003
05/28/2003CN1420786A Treatment of fungal infections with beta glucan synthase inhibitor antifungals combined with anti HSP90 antibodies
05/28/2003CN1420783A Compositions and methods for tumor-targeted delivery of effector molecules
05/28/2003CN1109740C Process for removing or bleaching soils or stains from cellulosic fabric
05/27/2003US6569997 Antibody specific for H4-1BB
05/27/2003US6569420 Human interferon-ε: a type I interferon
05/27/2003CA2158455C Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide and their uses in vaccines and disease treatments
05/22/2003WO2003042693A2 Method for measuring intracellular atp and/or gene expression
05/22/2003WO2003042249A2 Peptide purification by means of metal ion affinity chromatography
05/22/2003WO2003042247A2 Modified anti-tnf alpha antibody
05/22/2003WO2003042240A2 Polypeptides of pseudomonas aeruginosa
05/22/2003WO2002102836A3 Moraxella (branhamella) catarrhalis antigens
05/22/2003WO2002068653A3 Tri-hybrid melanoma antigen
05/22/2003WO2002046768A3 Proteins, genes and their use for diagnosis and treatment of chronic asthma
05/22/2003WO2001068708A9 Human and humanized fap-alpha-specific antibodies
05/22/2003US20030097670 For producing and isolating homogeneous proteins
05/22/2003US20030096953 Protein mixture for use in the detection of microbiocides
05/22/2003US20030096756 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/22/2003US20030096749 Human cytokine receptor
05/22/2003US20030096402 Chemically defined medium for cultured mammalian cells
05/22/2003US20030096370 Gram negative bacterial protein for use in the prevention and treatment of bacterial infection
05/22/2003US20030096352 Nucleotide sequences coding polypeptides for use in the treatment and prevention of viral and bacterial disease
05/22/2003US20030096350 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/22/2003US20030096320 Oil bodies and associated proteins as affinity matrices
05/22/2003US20030096313 Novel serine-threonine kinase-4
05/22/2003US20030096312 Novel natrium-calcium exchanger protein
05/22/2003US20030096306 Intrabodies with defined framework that is stable in a reducing environment and applications thereof
05/22/2003US20030096282 Gtpase-activating protein 1
05/22/2003US20030095973 Chlamydia antigens and corresponding DNA fragments and uses thereof
05/22/2003US20030095964 Process for producing humanized chimera antibody
05/22/2003CA2784450A1 Polypeptides of pseudomonas aeruginosa
05/22/2003CA2467433A1 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
05/22/2003CA2466592A1 Modified anti-tnf alpha antibody
05/22/2003CA2464942A1 Signal system and elements used therein
05/21/2003EP1311684A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
05/21/2003EP1311679A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
05/21/2003EP1311678A2 Cripto tumour polypeptide
05/21/2003EP1311674A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1311673A2 Compositions and methods for the therapy and diagnosis of prostate cancer
05/21/2003EP1311668A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1311549A2 Composition for the elimination of autoreactive b-cells
05/21/2003EP1311537A2 Identification of a cam-kinase ii inhibitor
05/21/2003EP1311162A2 Bacillus thurigiensis crystal protein hybrids
05/21/2003EP1015593B1 Hepatitis b virus polypeptides
05/21/2003EP0573551B1 Serine-rich peptide linkers
05/21/2003CN1419565A Chimeric Prostate-homing peptides with pro-apoptotic activity
05/20/2003US6566085 Synthetic peptides, antibodies directed against them, and the use thereof
05/20/2003US6566084 Detecting hydrolysis of cocaine compound; obtain cocaine mixture, incubate with antibody, monitor generation of benzoic zacid
05/20/2003US6566077 Qualitative or quantitative analysis of immunoglobulin; generate solid support, incubate with immunoglobulin mixture, wash microtiter plate, detect complexed immunoglobulin
05/20/2003US6565856 Polypeptide; inducting immunology response
05/20/2003US6565848 Cadherin-like asymmetry protein-1, and methods for its use
05/20/2003CA2131551C Conjugates formed from heat shock proteins and oligo- or polysaccharides
05/15/2003WO2003040695A2 Protein knobs
05/15/2003WO2003040391A2 Method for producing and identifying soluble protein domains
05/15/2003WO2003040345A2 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003WO2003040313A2 Il-21 antagonists
05/15/2003WO2003040164A2 Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003WO2003039491A2 Novel isoforms of vascular endothelial cell growth inhibitor
05/15/2003WO2002057451A9 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein
05/15/2003WO2002055108A9 Targeted modification of intracellular compounds
05/15/2003WO2002029059A9 Nogo receptor homologs
05/15/2003US20030092894 Conjugated antigen for use as tool in the treatment of cancer
05/15/2003US20030092892 Crosslinking, agglutination, purification
05/15/2003US20030092891 Expressed ligand - vascular intercellular signalling molecule
05/15/2003US20030092881 Polypeptide for use in diagnosis and treatment of gastrointestinal disorders
05/15/2003US20030092624 Denaturant (boiling and/or detergent) stable; various uses including de-aggregating and/or preventing aggregation of an aggregating protein such as beta-amyloid or prions, restoring enzyme activity, and immunization using fusion protein
05/15/2003US20030092613 Alpha7 nicotinic receptor peptides as ligands for beta amyloid peptides
05/15/2003US20030092604 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
05/15/2003US20030092164 Polypeptide use in the treatment of cell proliferative disorders
05/15/2003US20030092070 Genetic construct intracellular monitoring system
05/15/2003US20030092069 Hollow nanoparticle for use in the transfer of biopolymer into cells
05/15/2003US20030092054 Protein complexes and assays for screening anti-cancer agents
05/15/2003US20030092044 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders
05/15/2003US20030092025 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment, prevention of tumor disorders
05/15/2003US20030091582 Autoimmune diseases; antitumor agents; antiallergens
05/15/2003US20030091569 Methods for the treatment of carcinoma
05/15/2003US20030091561 Anticancer agents
05/15/2003CA2466595A1 Protein knobs
05/15/2003CA2466492A1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003CA2465953A1 Novel isoforms of vascular endothelial cell growth inhibitor
05/15/2003CA2464765A1 Type 2 cytokine receptor and nucleic acids encoding same
05/14/2003EP1310558A2 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
05/14/2003EP1310552A2 Posh nucleic acids, polypeptides and related methods
05/14/2003EP1309690A2 Mfq-111, a novel human gtpase like protein
05/14/2003EP1309687A2 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof
05/14/2003EP1309685A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309620A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
05/14/2003EP1309606A1 T1r taste receptors and genes encoding same
05/14/2003EP1309347A2 Method and composition for altering a b cell mediated pathology
05/14/2003EP1309346A2 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists
05/14/2003EP1267940B1 Compounds for targeting
05/14/2003EP1140987B1 Peptides for inhibiting hpv e6 proteins
05/13/2003US6562787 Hybrid polypeptides with enhanced pharmacokinetic properties
05/13/2003US6562617 Library of fusion nucleic acids for use as diagnostic tools in genetic engineering
05/13/2003US6562563 Detection of modulator of mitochondrial permeability transition; obtain cell containing mitochondrion, incubate with modulator, exposing cell to excitation energy, detect energy transfer, compare to control
05/13/2003US6562346 Fusion protein consisting of NS3, NS4 and NS5a polypeptides of hepatitus C virus with epitopes selected from sequence number 1 and/or 2
05/13/2003US6562343 Compositions and methods for the treatment and diagnosis of immune disorders
05/08/2003WO2003037060A2 Compositions and methods for wt1 specific immunotherapy
05/08/2003WO2002072608A3 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS
05/08/2003WO2002020768A9 Caveolin peptides and their use as therapeutics
1 ... 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 ... 295